P.E.I. Suspends Use of Oxford AstraZeneca Vaccine for Those Aged 18-29

P.E.I. Suspends Use of Oxford AstraZeneca Vaccine for Those Aged 18-29
Dr. Joss Reimer, medical lead, Manitoba Vaccine Implementation Task Force draws a dose of the AstraZeneca COVID-19 vaccine at a clinic in Winnipeg, on March 19, 2021. John Woods/The Canadian Press
The Canadian Press
Updated:

CHARLOTTETOWN—Prince Edward Island has suspended use of the Oxford-AstraZeneca COVID-19 vaccine for those aged 18 to 29.

Health officials said in a brief statement the vaccination appointments are on hold pending further information expected today from Health Canada and the National Advisory Committee on Immunization.